Cardiff Oncology, Inc.
Public company- Headquarters
- SAN DIEGO, California
- Industry
- Biotechnology
- Ticker
- CRDF
- CIK
- 0001213037
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CMOLeila Alland | Oct 27, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
- Vaxart, Inc.
member of the Board appointed: Raquel C. Bono, M.D., M.B.A., FACS
- Caribou Biosciences, Inc.
Plant closure: Berkeley, CA
- Executive appointment
CMO appointed: Leila Alland
Leila Alland was named interim Chief Medical Officer of Cardiff Oncology, Inc., effective October 23, 2026. Leila Alland succeeds Roger Sidhu. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 27, 2026Role: interim Chief Medical Officer
Only one public record so far. We add events as soon as a new filing lands; watch Cardiff Oncology, Inc. to get them in your digest.
Last verified Nov 8, 2026